Mad in America
JUNE 15, 2024
His independent research into psychiatric drug harm and pharmaceutical industry corruption would eventually lead him to Mad in America, where he launched the Veterans’ & Military Families Initiative in 2019. Capitol for six days in the heat and rain to get help for their sick friends. military veterans.
Mad in America
OCTOBER 12, 2024
The US Food and Drug Administration (FDA) does not require warnings for persistent sexual dysfunction, for example, and today the agency is attempting to defend itself from a lawsuit by the consumer advocacy nonprofit Public Citizen, which claims that it failed to respond to a 2018 petition to do so. I understand these concerns all too well.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Santa Barbara Sanctuary Centers
DECEMBER 5, 2023
Sanctuary Centers, a nonprofit focused on providing care and housing for individuals suffering from mental illness, will host a groundbreaking ceremony on Thursday, December 14, for its five-story facility, which melds housing and healthcare services together in one building.
Santa Barbara Sanctuary Centers
DECEMBER 5, 2023
Sanctuary Centers, a nonprofit focused on providing care and housing for individuals suffering from mental illness, will host a groundbreaking ceremony on Thursday, December 14, for its five-story facility, which melds housing and health-care services together in one building.
The Maryland Psychiatric Society
FEBRUARY 27, 2025
Secretary-Treasurer 2018 2019, President-Elect 2019 -2020, President 2020 2021, Council Chair 2021 2022, Nominations and Elections Committee 2022 – present. Board Member, Maryland Foundation for Psychiatry, 2011 2018.
Mad in America
OCTOBER 10, 2023
Shire has since been bought out by Japan’s Takeda Pharmaceuticals, a 242-year-old company that made the purchase in 2019 to strengthen its footprint in the US drug market. For low-income areas, this service is very valuable for extra income, it helps reduce neighborhood waste and also helps out many nonprofit organizations with fundraising.
Mad in America
AUGUST 14, 2024
By 2019, two Phase 3 trials of aducanumab were terminated early because the drug wasn’t improving outcomes and was clearly causing harm (a large percentage of the participants were experiencing brain bleeding known as ARIA). And the FDA is not required to follow the advice of its advisory committees.
Expert insights. Personalized for you.
142 
Let's personalize your content